Download PDF
Neuropediatrics 2017; 48(01): 005-018
DOI: 10.1055/s-0036-1597271
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Febrile Infection–Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis

Andreas van Baalen
1   Department of Neuropediatrics, Christian-Albrechts-Universität zu Kiel, University Medical Center Schleswig-Holstein, Kiel, Germany
,
Annamaria Vezzani
2   Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri,” Milano, Italy
,
Martin Häusler
3   Division of Neuropediatrics and Social Pediatrics, Department of Pediatrics, University Hospital, RWTH Aachen, Aachen, Germany
,
Gerhard Kluger
4   Neuropediatric Clinic and Clinic for Neurorehabilitation, Epilepsy Center for Children and Adolescents, Vogtareuth, Germany
5   Paracelsus Medical University Salzburg, Austria
› Author Affiliations
Further Information

Publication History

05 July 2016

08 October 2016

Publication Date:
05 December 2016 (online)

   Permissions and Reprints

Abstract

Febrile infection–related epilepsy syndrome (FIRES, AERRPS, or DESC) is one of the most severe, mostly irreversible, and presumably immune-mediated epileptic encephalopathies affecting healthy children. Refractory status epilepticus or a cluster of seizures start a few days after the onset of an acute febrile illness; however, encephalitis cannot be proved. Sequelae of FIRES are drug-resistant epilepsy and neuropsychological impairments occurring without latency. Clinical knowledge is limited because FIRES is sporadic and extremely rare. Therefore, based on literature and our data, this review includes clinical features, terminology, epidemiology, diagnostic criteria and procedures, differential diagnoses, acute and chronic therapeutic options, and outcome data. Particular attention is paid to the epileptogenesis. We hypothesize that FIRES is an immune but not an autoimmune disease and discuss GABAergic therapy at high doses, avoidance of burst-suppression coma, and early introduction of enteral or even parenteral ketogenic diet as the most promising treatment. The lack of evidence requires both a network and a multinational web-based clinical registry to define the clinical spectrum for improving diagnosis and treatment and at the very least, to clarify the cause of FIRES. We conclude that the term “fulminant inflammatory response epilepsy syndrome” may be more appropriate.

Keywords

encephalitis - encephalopathy - epilepsy - FIRES - immunity - inflammation - status epilepticus
 

  • References

  • 1 van Baalen A, Häusler M, Boor R , et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010; 51 (7) 1323-1328
    CrossrefPubMedGoogle Scholar
  • 2 Gupta P, Patel S, Ranjan R, Agrawal CS. An interesting case of super-refractory status epilepticus. Neurol India 2015; 63 (4) 628-629
    CrossrefPubMedGoogle Scholar
  • 3 van Baalen A, Häusler M, Plecko-Startinig B , et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics 2012; 43 (4) 209-216
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Covanis A. Epileptic encephalopathies (including severe epilepsy syndromes). Epilepsia 2012; 53 (Suppl. 04) 114-126
    CrossrefPubMedGoogle Scholar
  • 5 Lyon G, Dodge PR, Adams RD. The acute encephalopathies of obscure origin in infants and children. Brain 1961; 84: 680-708
    CrossrefPubMedGoogle Scholar
  • 6 Sakuma H, Fukumizu M, Kohyama J. [Efficacy of anticonvulsants on acute encephalitis with refractory, repetitive partial seizures (AERRPS)]. No To Hattatsu 2001; 33 (5) 385-390
    PubMedGoogle Scholar
  • 7 Mikaeloff Y, Jambaqué I, Hertz-Pannier L , et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res 2006; 69 (1) 67-79
    CrossrefPubMedGoogle Scholar
  • 8 Kluger G, Granel M, Holthausen H. Refractory status epilepticus after non-specific infection in 3 previously healthy children. Abstracts of the 31st Annual Meeting of the Society for Neuropediatrics. Neuropediatrics 2012; 36 (2) P69
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 van Baalen A, Stephani U, Kluger G, Häusler M, Dulac O. FIRES: febrile infection responsive epileptic (FIRE) encephalopathies of school age. Brain Dev 2009; 31 (1) 91 , author reply 92–93
    CrossrefPubMedGoogle Scholar
  • 10 Nabbout R, Mazzuca M, Hubert P , et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010; 51 (10) 2033-2037
    CrossrefPubMedGoogle Scholar
  • 11 Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011; 134 (Pt 10): 2802-2818
    CrossrefPubMedGoogle Scholar
  • 12 Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011; 10 (1) 99-108
    CrossrefPubMedGoogle Scholar
  • 13 Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities?. Epilepsia 2011; 52 (11) e185-e189
    CrossrefPubMedGoogle Scholar
  • 14 Striano P, Pezzella M, Brigati G, Minetti C. Lumping encephalopathies with inflammation-mediated status epilepticus: is there enough evidence?. Epilepsy Behav 2011; 20 (3) 592
    CrossrefPubMedGoogle Scholar
  • 15 Körtvelyessy P, Lerche H, Weber Y. FIRES and NORSE are distinct entities. Epilepsia 2012; 53 (7) 1276
    CrossrefPubMedGoogle Scholar
  • 16 Appenzeller S, Helbig I, Stephani U , et al. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations. Dev Med Child Neurol 2012; 54 (12) 1144-1148
    CrossrefPubMedGoogle Scholar
  • 17 Pasca L, De Giorgis V, Macasaet JA, Trentani C, Tagliabue A, Veggiotti P. The changing face of dietary therapy for epilepsy. Eur J Pediatr 2016; 175 (10) 1267-1276
    CrossrefPubMedGoogle Scholar
  • 18 Farias-Moeller R, Bartolini L, Pasupuleti A, Brittany Cines RD, Kao A, Carpenter JL. A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus. Neurocrit Care 2016; DOI: 10.1007/s12028-016-0312-4.
    PubMedGoogle Scholar
  • 19 Jung DE, Kang HC, Lee JS, Lee EJ, Kim HD. Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy. Brain Dev 2012; 34 (8) 620-624
    CrossrefPubMedGoogle Scholar
  • 20 Zupec-Kania B, Neal E, Schultz R, Roan ME, Turner Z, Welborn M. An update on diets in clinical practice. J Child Neurol 2013; 28 (8) 1015-1026
    CrossrefPubMedGoogle Scholar
  • 21 Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS ; CHEESE Study Group. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient. Pediatr Neurol 2015; 52 (4) 442-445
    CrossrefPubMedGoogle Scholar
  • 22 Chiusolo F, Diamanti A, Bianchi R , et al. From intravenous to enteral ketogenic diet in PICU: A potential treatment strategy for refractory status epilepticus. Eur J Paediatr Neurol 2016; 20 (6) 843-847
    CrossrefPubMedGoogle Scholar
  • 23 Byun JI, Chu K, Sunwoo JS , et al. Mega-dose phenobarbital therapy for super-refractory status epilepticus. Epileptic Disord 2015; 17 (4) 444-452
    CrossrefPubMedGoogle Scholar
  • 24 Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol 2013; 244: 11-21
    CrossrefPubMedGoogle Scholar
  • 25 Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology 2013; 69: 16-24
    CrossrefPubMedGoogle Scholar
  • 26 Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Curr 2014; 14 (1 Suppl) 3-7
    CrossrefPubMedGoogle Scholar
  • 27 Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7 (1) 31-40
    CrossrefPubMedGoogle Scholar
  • 28 Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011; 25 (7) 1281-1289
    CrossrefPubMedGoogle Scholar
  • 29 Miskin C, Hasbani DM. Status epilepticus: immunologic and inflammatory mechanisms. Semin Pediatr Neurol 2014; 21 (3) 221-225
    CrossrefPubMedGoogle Scholar
  • 30 Varadkar S, Cross JH. Rasmussen syndrome and other inflammatory epilepsies. Semin Neurol 2015; 35 (3) 259-268
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Riazi K, Galic MA, Pittman QJ. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 2010; 89 (1) 34-42
    CrossrefPubMedGoogle Scholar
  • 32 Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol 2012; 33 (1) 116-125
    CrossrefPubMedGoogle Scholar
  • 33 Dubé CM, Ravizza T, Hamamura M , et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 2010; 30 (22) 7484-7494
    CrossrefPubMedGoogle Scholar
  • 34 Vezzani A, Dingledine R, Rossetti AO. Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother 2015; 15 (9) 1081-1092
    CrossrefPubMedGoogle Scholar
  • 35 Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 2015; 96 (Pt 0A) 70-82
    CrossrefPubMedGoogle Scholar
  • 36 De Simoni MG, Perego C, Ravizza T , et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000; 12 (7) 2623-2633
    CrossrefPubMedGoogle Scholar
  • 37 Aronica E, Boer K, van Vliet EA , et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007; 26 (3) 497-511
    CrossrefPubMedGoogle Scholar
  • 38 Ravizza T, Boer K, Redeker S , et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006; 24 (1) 128-143
    CrossrefPubMedGoogle Scholar
  • 39 Wakamoto H, Takahashi Y, Ebihara T , et al. An immunologic case study of acute encephalitis with refractory, repetitive partial seizures. Brain Dev 2012; 34 (9) 763-767
    CrossrefPubMedGoogle Scholar
  • 40 Sakuma H, Tanuma N, Kuki I, Takahashi Y, Shiomi M, Hayashi M. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry 2015; 86 (7) 820-822
    CrossrefPubMedGoogle Scholar
  • 41 Reschke CR, Henshall DC. microRNA and epilepsy. Adv Exp Med Biol 2015; 888: 41-70
    PubMedGoogle Scholar
  • 42 Carpentier PA, Palmer TD. Immune influence on adult neural stem cell regulation and function. Neuron 2009; 64 (1) 79-92
    CrossrefPubMedGoogle Scholar
  • 43 Vezzani A, Friedman A. Brain inflammation as a biomarker in epilepsy. Biomarkers Med 2011; 5 (5) 607-614
    CrossrefPubMedGoogle Scholar
  • 44 Silveira G, de Oliveira AC, Teixeira AL. Insights into inflammation and epilepsy from the basic and clinical sciences. J Clin Neurosci 2012; 19 (8) 1071-1075
    CrossrefPubMedGoogle Scholar
  • 45 Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends Neurosci 2014; 37 (2) 55-65
    CrossrefPubMedGoogle Scholar
  • 46 Rosas-Ballina M, Tracey KJ. The neurology of the immune system: neural reflexes regulate immunity. Neuron 2009; 64 (1) 28-32
    CrossrefPubMedGoogle Scholar
  • 47 Patil SB, Roy AG, Vinayan KP. Clinical profile and treatment outcome of febrile infection-related epilepsy syndrome in South Indian children. Ann Indian Acad Neurol 2016; 19 (2) 188-194
    CrossrefPubMedGoogle Scholar
  • 48 El Sabbagh S, Lebre AS, Bahi-Buisson N , et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010; 51 (7) 1225-1235
    CrossrefPubMedGoogle Scholar
  • 49 Bindoff LA. Mitochondrial function and pathology in status epilepticus. Epilepsia 2011; 52 (Suppl. 08) 6-7
    CrossrefPubMedGoogle Scholar
  • 50 Johnson KB, Michelson KA, Lyons TW , et al. Pediatric status epilepticus: how common is cerebrospinal fluid pleocytosis in the absence of infection?. Seizure 2014; 23 (7) 573-575
    CrossrefPubMedGoogle Scholar
  • 51 Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S. Effect of epileptic seizures on the cerebrospinal fluid--A systematic retrospective analysis. Epilepsy Res 2015; 114: 23-31
    CrossrefPubMedGoogle Scholar
  • 52 Suleiman J, Dale RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol 2015; 57 (5) 431-440
    CrossrefPubMedGoogle Scholar
  • 53 Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia 2013; 54 (6) 1036-1045
    CrossrefPubMedGoogle Scholar
  • 54 Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 2014; 27 (3) 361-368
    CrossrefPubMedGoogle Scholar
  • 55 Antoine JC. Autoimmune encephalitis: paving the way for early diagnosis. Lancet Neurol 2016; 15 (4) 349-350
    CrossrefPubMedGoogle Scholar
  • 56 Graus F, Titulaer MJ, Balu R , et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (4) 391-404
    Google Scholar
  • 57 Benson LA, Olson H, Gorman MP. Evaluation and treatment of autoimmune neurologic disorders in the pediatric intensive care unit. Semin Pediatr Neurol 2014; 21 (4) 284-290
    CrossrefPubMedGoogle Scholar
  • 58 Salzberg SL, Breitwieser FP, Kumar A , et al. Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system. Neurol Neuroimmunol Neuroinflamm 2016; 3 (4) e251
    CrossrefPubMedGoogle Scholar
  • 59 Cartagena AM, Young GB, Lee DH, Mirsattari SM. Reversible and irreversible cranial MRI findings associated with status epilepticus. Epilepsy Behav 2014; 33: 24-30
    CrossrefPubMedGoogle Scholar
  • 60 Nozaki F, Kumada T, Miyajima T , et al. Reversible splenic lesion in a patient with febrile infection-related epilepsy syndrome (FIRES). Neuropediatrics 2013; 44 (5) 291-294
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Agarwal A, Sabat S, Thamburaj K, Kanekar S. Hippocampal changes in febrile infection-related epilepsy syndrome (FIRES). Pol J Radiol 2015; 80: 391-394
    CrossrefPubMedGoogle Scholar
  • 62 Finetti C, Gerling CH, Schlump JU, Utz N, Schweiger T. Reversible cMRI changes after status epilepticus: two case reports and a review. Abstracts of the 42nd Annual Meeting of the Society for Neuropediatrics. Neuropediatrics 2016; 47 (S1): P01-20
    PubMedGoogle Scholar
  • 63 Kobayashi K, Ouchida M, Okumura A , et al. Genetic seizure susceptibility underlying acute encephalopathies in childhood. Epilepsy Res 2010; 91 (2-3): 143-152
    CrossrefPubMedGoogle Scholar
  • 64 Kobayashi K, Ohzono H, Shinohara M , et al. Acute encephalopathy with a novel point mutation in the SCN2A gene. Epilepsy Res 2012; 102 (1-2): 109-112
    CrossrefPubMedGoogle Scholar
  • 65 Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54 (7) 899-904
    CrossrefPubMedGoogle Scholar
  • 66 Sato Y, Numata-Uematsu Y, Uematsu M , et al. Acute encephalitis with refractory, repetitive partial seizures: pathological findings and a new therapeutic approach using tacrolimus. Brain Dev 2016; 38 (8) 772-776
    CrossrefPubMedGoogle Scholar
  • 67 Melvin JJ, Huntley Hardison H. Immunomodulatory treatments in epilepsy. Semin Pediatr Neurol 2014; 21 (3) 232-237
    CrossrefPubMedGoogle Scholar
  • 68 Geva-Dayan K, Shorer Z, Menascu S , et al. Immunoglobulin treatment for severe childhood epilepsy. Pediatr Neurol 2012; 46 (6) 375-381
    CrossrefPubMedGoogle Scholar
  • 69 Nosadini M, Mohammad SS, Suppiej A, Sartori S, Dale RC ; IVIG in Neurology Study Group. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome. Dev Med Child Neurol 2016; 58 (11) 1180-1192
    CrossrefPubMedGoogle Scholar
  • 70 Aguglia U, Sueri C, Gasparini S , et al; Epilepsy Study Group of the Italian Neurological Society and of the Subcommission on Status Epilepticus of the Italian League Against Epilepsy. Relevance of clinical context in the diagnostic-therapeutic approach to status epilepticus. Epilepsia 2016; 57 (9) 1527-1529
    CrossrefPubMedGoogle Scholar
  • 71 Kramer U, Chi CS, Lin KL , et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011; 52 (11) 1956-1965
    CrossrefPubMedGoogle Scholar
  • 72 Kramer U, Chi CS, Lin KL , et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome?. Epilepsia 2011; 52 (Suppl. 08) 28-30
    PubMedGoogle Scholar
  • 73 Sutter R, Kaplan PW. Can anesthetic treatment worsen outcome in status epilepticus?. Epilepsy Behav 2015; 49: 294-297
    CrossrefPubMedGoogle Scholar
  • 74 Bellante F, Legros B, Depondt C, Créteur J, Taccone FS, Gaspard N. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. J Neurol 2016; 263 (4) 799-806
    CrossrefPubMedGoogle Scholar
  • 75 Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012; 25 (2) 173-178
    CrossrefPubMedGoogle Scholar
  • 76 Nangia S, Caraballo RH, Kang HC, Nordli DR, Scheffer IE. Is the ketogenic diet effective in specific epilepsy syndromes?. Epilepsy Res 2012; 100 (3) 252-257
    CrossrefPubMedGoogle Scholar
  • 77 Singh RK, Joshi SM, Potter DM, Leber SM, Carlson MD, Shellhaas RA. Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet. Pediatrics 2014; 134 (5) e1431-e1435
    CrossrefPubMedGoogle Scholar
  • 78 Chang P, Augustin K, Boddum K , et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 2016; 139 (Pt 2): 431-443
    CrossrefPubMedGoogle Scholar
  • 79 Dupuis N, Curatolo N, Benoist JF, Auvin S. Ketogenic diet exhibits anti-inflammatory properties. Epilepsia 2015; 56 (7) e95-e98
    CrossrefPubMedGoogle Scholar
  • 80 Baumeister FA, Oberhoffer R, Liebhaber GM , et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004; 35 (4) 250-252
    Article in Thieme ConnectPubMedGoogle Scholar
  • 81 Gofshteyn JS, Wilfong A, Devinsky O , et al. Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases. J Child Neurol 2016; DOI: 10.1177/0883073816669450.
    PubMedGoogle Scholar
  • 82 Rosemergy I, Adler J, Psirides A. Cannabidiol oil in the treatment of super refractory status epilepticus. A case report. Seizure 2016; 35: 56-58
    CrossrefPubMedGoogle Scholar
  • 83 Devinsky O, Cilio MR, Cross H , et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 2014; 55 (6) 791-802
    CrossrefPubMedGoogle Scholar
  • 84 Devinsky O, Marsh E, Friedman D , et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 2016; 15 (3) 270-278
    CrossrefPubMedGoogle Scholar
  • 85 Ogawa C, Natsume J, Yamamoto H , et al. Autopsy findings of a patient with acute encephalitis and refractory, repetitive partial seizures. Seizure 2016; 35: 80-82
    CrossrefPubMedGoogle Scholar
  • 86 Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012; 27 (11) 1460-1469
    CrossrefPubMedGoogle Scholar
  • 87 Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 2016; 12 (1) 1-13
    Google Scholar
  • 88 Rivas-Coppola MS, Shah N, Choudhri AF, Morgan R, Wheless JW. Chronological evolution of magnetic resonance imaging findings in children with febrile infection-related epilepsy syndrome. Pediatr Neurol 2016; 55: 22-29
    CrossrefPubMedGoogle Scholar
  • 89 Dunleavy M, Shinoda S, Schindler C , et al. Experimental neonatal status epilepticus and the development of temporal lobe epilepsy with unilateral hippocampal sclerosis. Am J Pathol 2010; 176 (1) 330-342
    CrossrefPubMedGoogle Scholar
  • 90 Roch C, Leroy C, Nehlig A, Namer IJ. Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 2002; 43 (10) 1129-1136
    CrossrefPubMedGoogle Scholar
  • 91 Howell KB, Katanyuwong K, Mackay MT , et al. Long-term follow-up of febrile infection-related epilepsy syndrome. Epilepsia 2012; 53 (1) 101-110
    CrossrefPubMedGoogle Scholar
  • 92 Bausell R, Svoronos A, Lennihan L, Hirsch LJ. Recovery after severe refractory status epilepticus and 4 months of coma. Neurology 2011; 77 (15) 1494-1495
    CrossrefPubMedGoogle Scholar
  • 93 Korff C, Fluss J, Valenza N , et al. Febrile infection responsive encephalopathy of school-age (FIRES) with unexpected favorable evolution. Epilepsia 2009; 50 (Suppl. 12) 84
    PubMedGoogle Scholar
  • 94 Capovilla G, Wolf P, Beccaria F, Avanzini G. The history of the concept of epileptic encephalopathy. Epilepsia 2013; 54 (Suppl. 08) 2-5
    PubMedGoogle Scholar
  • 95 Saitoh M, Kobayashi K, Ohmori I , et al. Cytokine-related and sodium channel polymorphism as candidate predisposing factors for childhood encephalopathy FIRES/AERRPS. J Neurol Sci 2016; 368: 272-276
    CrossrefPubMedGoogle Scholar
  • 96 Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune responses in epilepsy. Glia 2012; 60 (8) 1258-1268
    CrossrefPubMedGoogle Scholar
  • 97 Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012; 11 (8) 633-652
    CrossrefPubMedGoogle Scholar
  • 98 Kenney DL, Kahoud RJ, Vezzani A , et al. Super-refractory status epilepticus and febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol 2016; DOI: 10.1002/ana.24806.
    PubMedGoogle Scholar
  • 99 Pillai SC, Mohammad SS, Hacohen Y , et al. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: clinical and etiologic risk factors. Epilepsia 2016; 57 (1) e7-e11
    CrossrefPubMedGoogle Scholar
  • 100 Cianfoni A, Caulo M, Cerase A , et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol 2013; 82 (11) 1964-1972
    CrossrefPubMedGoogle Scholar
  • 101 Sarria-Estrada S, Toledo M, Lorenzo-Bosquet C , et al. Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radiol 2014; 69 (8) 795-803
    CrossrefPubMedGoogle Scholar
  • 102 Mohammad SS, Soe SM, Pillai SC , et al. Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis. Clin Neurophysiol 2016; 127 (10) 3217-3224
    CrossrefPubMedGoogle Scholar
  • 103 Baysal-Kirac L, Tuzun E, Altindag E , et al. Are there any specific EEG findings in autoimmune encephalitis?. Clin EEG Neurosci 2016; 47 (3) 224-234
    CrossrefPubMedGoogle Scholar
  • 104 Bigi S, Hladio M, Twilt M, Dalmau J, Benseler SM. The growing spectrum of antibody-associated inflammatory brain diseases in children. Neurol Neuroimmunol Neuroinflamm 2015; 2 (3) e92
    CrossrefPubMedGoogle Scholar
  • 105 Mazzuca M, Jambaque I, Hertz-Pannier L , et al. 18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med 2011; 52 (1) 40-47
    CrossrefPubMedGoogle Scholar
  • 106 Cross JH. Fever and fever-related epilepsies. Epilepsia 2012; 53 (Suppl. 04) 3-8
    PubMedGoogle Scholar
  • 107 Venkatesan A, Tunkel AR, Bloch KC , et al; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57 (8) 1114-1128
    CrossrefPubMedGoogle Scholar
  • 108 Wolf NI, Rahman S, Schmitt B , et al. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009; 50 (6) 1596-1607
    CrossrefPubMedGoogle Scholar
  • 109 Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm 2015; DOI: 10.1155/2015/792578.
    PubMedGoogle Scholar
  • 110 Specchio N, Marini C, Terracciano A , et al. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations. Epilepsia 2011; 52 (7) 1251-1257
    CrossrefPubMedGoogle Scholar
  • 111 Tsuji M, Mazaki E, Ogiwara I , et al. Acute encephalopathy in a patient with Dravet syndrome. Neuropediatrics 2011; 42 (2) 78-81
    Article in Thieme ConnectPubMedGoogle Scholar
  • 112 Elbers J, Halliday W, Hawkins C, Hutchinson C, Benseler SM. Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol 2010; 68 (5) 602-610
    CrossrefPubMedGoogle Scholar
  • 113 Yamada K, Miura K, Hara K , et al. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet 2010; 11: 171
    CrossrefPubMedGoogle Scholar
  • 114 Tabarki B, Al-Shafi S, Al-Shahwan S , et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology 2013; 80 (3) 261-267
    CrossrefPubMedGoogle Scholar
  • 115 Karall D, Haberlandt E, Albrecht U, Rostasy K, Häberle J, Scholl-Bürgi S. Unrecognized citrullinemia mimicking encephalitis in a 14-year-old boy: unexpected result through the use of a standardized lumbar puncture protocol. Neuropediatrics 2012; 43 (2) 59-63
    Article in Thieme ConnectPubMedGoogle Scholar
  • 116 Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006; 32 (12) 2070-2076
    CrossrefPubMedGoogle Scholar
  • 117 Fernandez A, Lantigua H, Lesch C , et al. High-dose midazolam infusion for refractory status epilepticus. Neurology 2014; 82 (4) 359-365
    CrossrefPubMedGoogle Scholar
  • 118 Ueda R, Saito Y, Ohno K , et al. Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase. Brain Dev 2015; 37 (5) 471-477
    CrossrefPubMedGoogle Scholar
  • 119 Shiloh-Malawsky Y, Fan Z, Greenwood R, Tennison M. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure 2011; 20 (7) 586-588
    CrossrefPubMedGoogle Scholar
  • 120 Ilvento L, Rosati A, Marini C, L'Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav 2015; 49: 343-346
    CrossrefPubMedGoogle Scholar
  • 121 Capizzi G, Vittorini R, Torta F , et al. Lidocaine treatment in refractory status epilepticus resulting from febrile infection-related epilepsy syndrome: a case report and follow-up. Neuropediatrics 2015; 46 (1) 65-68
    PubMedGoogle Scholar
  • 122 Lin JJ, Lin KL, Wang HS, Hsia SH, Wu CT. Effect of topiramate, in combination with lidocaine, and phenobarbital, in acute encephalitis with refractory repetitive partial seizures. Brain Dev 2009; 31 (8) 605-611
    CrossrefPubMedGoogle Scholar
  • 123 Chou IC, Lai HC, Tsai FJ , et al. Marked improvement in febrile infection-related epilepsy syndrome after lidocaine plus MgSO4 treatment in a 12-year-old girl. Epilepsy Behav Case Rep 2016; 6: 6-9
    PubMedGoogle Scholar
  • 124 Fugate JE, Burns JD, Wijdicks EF, Warner DO, Jankowski CJ, Rabinstein AA. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe?. Anesth Analg 2010; 111 (6) 1520-1524
    CrossrefPubMedGoogle Scholar
  • 125 Lin JJ, Lin KL, Hsia SH, Wang HS ; CHEESE Study Group. Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr Neurol 2012; 47 (6) 448-450
    CrossrefPubMedGoogle Scholar
  • 126 Tan WW, Chan DWS, Lee JH, Thomas T, Menon AP, Chan YH. Use of magnesium sulfate infusion for the management of febrile illness-related epilepsy syndrome: a case series. Child Neurology Open 2015; 2: 1-5
    PubMedGoogle Scholar
  • 127 Häusler M, Schoberer M, van Baalen A , et al. FIRES (febrile infection-related epilepsy syndrome) partially responsive to magnesium and dextromethorphan treatment. Abstracts of the 38th Annual Meeting of the Society of Neuropediatrics. Neuropediatrics 2012; 43 (2) PS19_06
    Article in Thieme ConnectPubMedGoogle Scholar
  • 128 Muehlebner A, Groeppel G, Pahs G , et al. Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res 2010; 90 (3) 295-299
    CrossrefPubMedGoogle Scholar
  • 129 Vezzani A, Moneta D, Conti M , et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000; 97 (21) 11534-11539
    CrossrefPubMedGoogle Scholar
  • 130 Vezzani A, Moneta D, Richichi C , et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002; 43 (Suppl. 05) 30-35
    CrossrefPubMedGoogle Scholar
  • 131 Marchi N, Fan Q, Ghosh C , et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009; 33 (2) 171-181
    CrossrefPubMedGoogle Scholar
  • 132 Veiga AM, Moreno DC, Menéndez AIG , et al. Effectiveness of electroconvulsive therapy for refractory status epilepticus in febrile infection-related epilepsy syndrome. Neuropediatrics 2016; DOI: 10.1055/s-0036-1584939.
    PubMedGoogle Scholar
  • 133 Wasterlain CG, Baldwin R, Naylor DE, Thompson KW, Suchomelova L, Niquet J. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia 2011; 52 (Suppl. 08) 70-71
    PubMedGoogle Scholar
  • 134 Holzer FJ, Seeck M, Korff CM. Autoimmunity and inflammation in status epilepticus: from concepts to therapies. Expert Rev Neurother 2014; 14 (10) 1181-1202
    CrossrefPubMedGoogle Scholar
  • 135 Specchio N, Fusco L, Claps D , et al. Childhood refractory focal epilepsy following acute febrile encephalopathy. Eur J Neurol 2011; 18 (7) 952-961
    CrossrefPubMedGoogle Scholar
  • 136 Illingworth MA, Hanrahan D, Anderson CE , et al. Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol 2011; 53 (11) 1053-1057
    CrossrefPubMedGoogle Scholar
  • 137 Sivakumar S, Ibrahim M, Parker Jr D, Norris G, Shah A, Mohamed W. Clobazam: an effective add-on therapy in refractory status epilepticus. Epilepsia 2015; 56 (6) e83-e89
    CrossrefPubMedGoogle Scholar
  • 138 Palencia G, Martinez-Juarez IE, Calderon A, Artigas C, Sotelo J. Thalidomide for treatment of refractory epilepsy. Epilepsy Res 2010; 92 (2-3): 253-257
    CrossrefPubMedGoogle Scholar